000066:SSEChina Greatwall Technology Group Co., Ltd. Analysis
Data as of 2026-03-17 - not real-time
CN¥16.19
Latest Price
7/10Risk
Risk Level: Medium
Executive Summary
Technical momentum remains positive – the stock trades above its 20‑day and 50‑day moving averages, the MACD histogram is in bullish territory and volume is on the rise, suggesting short‑term buying pressure.
However, fundamental fundamentals are weak: earnings are negative, profit margins are in the red, debt levels are high relative to equity, and a discounted cash‑flow model values the company at a fraction of its current price, indicating significant overvaluation. The combination of high recent volatility and a sizable recent drawdown adds to the downside risk. Investors should weigh the bullish technical backdrop against the deteriorating financial health before making a move.
However, fundamental fundamentals are weak: earnings are negative, profit margins are in the red, debt levels are high relative to equity, and a discounted cash‑flow model values the company at a fraction of its current price, indicating significant overvaluation. The combination of high recent volatility and a sizable recent drawdown adds to the downside risk. Investors should weigh the bullish technical backdrop against the deteriorating financial health before making a move.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 5/10
Key Factors
- Bullish technical indicators (price above SMAs, bullish MACD)
- Increasing trading volume supporting short‑term momentum
- Negative earnings and high debt limiting upside
Medium Term
1–3 yearsCautious
Model confidence: 7/10
Key Factors
- Severe overvaluation relative to DCF fair value
- Sustained negative profitability and weak cash conversion
- Elevated volatility and recent drawdown exposing downside risk
Long Term
> 3 yearsCautious
Model confidence: 8/10
Key Factors
- Fundamental structural issues: high leverage, negative ROE/ROA
- Lack of dividend income and uncertain turnaround prospects
- Sector and regulatory environment in China adding long‑run uncertainty
Key Metrics & Analysis
Financial Health
Revenue Growth11.30%
Profit Margin-5.20%
P/E Ratio231.3
ROE-5.88%
ROA-2.54%
Debt/Equity80.62
P/B Ratio4.7
Op. Cash FlowCN¥173.6M
Free Cash FlowCN¥620.7M
Industry P/E34.2
Technical Analysis
TrendBullish
RSI48.6
SupportCN¥15.07
ResistanceCN¥17.60
MA 20CN¥16.34
MA 50CN¥16.13
MA 200CN¥15.75
MACDBullish
VolumeIncreasing
Fear & Greed Index79.45
Valuation
Fair ValueCN¥2.47
GradeOvervalued
TypeValue
Risk Assessment
Beta-0.11
Volatility49.95%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.